4.7 Review

The bacterial skin microbiome in psoriatic arthritis, an unexplored link in pathogenesis: challenges and opportunities offered by recent technological advances

Journal

RHEUMATOLOGY
Volume 53, Issue 5, Pages 777-784

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/ket319

Keywords

skin microbiome; psoriatic arthritis; next-generation sequencing; metagenomics

Categories

Funding

  1. National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit Fellowship Award
  2. Arthritis Research UK [20385]
  3. Eli Lilly
  4. Pfizer
  5. Abbvie
  6. Amgen
  7. Wyeth/Pfizer

Ask authors/readers for more resources

The resident microbial community, harboured by humans in sites such as the skin and gastrointestinal tract, is enormous, representing a candidate environmental factor affecting susceptibility to complex diseases, where both genetic and environmental risk factors are important. The potential of microorganisms to influence the human immune system is considerable, given their ubiquity. The impact of the host-gene-microbe interaction on the maintenance of health and the development of disease has not yet been assessed robustly in chronic inflammatory conditions. PsA represents a model inflammatory disease to explore the role of the microbiome because skin involvement and overlap with IBD implicates both the skin and gastrointestinal tract as sources of microbial triggers for PsA. In parallel with genetic studies, characterization of the host microbiota may benefit our understanding of the microbial contribution to disease pathogenesis-knowledge that may eventually inform the development of novel therapeutics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available